GoodRx and GEO Group Top Expectations, Outlook Miss
- August 09th, 2023
- 473 views
GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projected revenue of $186.82 million. However, GoodRx anticipates Q3 revenue to range between approximately $186 million and $190 million, contrasting with the consensus estimate of $192.58 million for the period.
$GDRX was trading at $8.65 in pre-market, reflecting a decrease of $0.09 (-1.03%).
Shifting focus, The GEO Group, Inc. (NYSE: GEO) reported earnings of $0.24 per share for Q2 2023, surpassing the consensus EPS estimate of $0.20. The company's quarterly revenues reached $593.90 million, exceeding the analysts' expected revenue of $588.26 million. GEO Group projects full-year 2023 revenues around $2.4 billion, slightly below the consensus estimate of $2.43 billion for the period.
In pre-market, $GEO was trading at $7.02, down $0.26 (-3.57%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login